Property | Value |
?:abstract
|
-
We read with interest the report published in Liver International by Colaneri et al. who presented a case of acute Hepatitis B Virus (HBV) infection occurring during the course of coronavirus disease 2019 (COVID-19), highlighting how difficult can be disentangling the responsibility of liver enzyme alteration in a patient with COVID-19, and more importantly how treatment decisions can be affected by both liver disease and severe acute respiratory syndrome coronavirus-2 infection.
|
is
?:annotates
of
|
|
?:creator
|
|
?:doi
|
|
?:doi
|
|
?:journal
|
-
Liver_international_:_official_journal_of_the_International_Association_for_the_Study_of_the_Liver
|
?:license
|
|
?:pmid
|
|
?:pmid
|
|
?:publication_isRelatedTo_Disease
|
|
is
?:relation_isRelatedTo_publication
of
|
|
?:source
|
|
?:title
|
-
COVID-19 and liver disease: not all evil comes to harm.
|
?:type
|
|
?:year
|
|